|Table of Contents|

Application of circulating tumor cells in diagnosis and treatment of NSCLC

Journal Of Modern Oncology[ISSN:1672-4992/CN:61-1415/R]

Issue:
2021 03
Page:
535-539
Research Field:
Publishing date:

Info

Title:
Application of circulating tumor cells in diagnosis and treatment of NSCLC
Author(s):
HE Yuxiao; LU Jibin
Department of Thoracic Surgery，Shengjing Hospital of China Medical University，Liaoning Shenyang 110000，China.
Keywords:
NSCLC; circulating tumor cells; diagnosis; prognosis; genetic testing
PACS:
R734.2
DOI:
DOI：10.3969/j.issn.1672-4992.2021.03.040
Abstract:
Lung cancer is one of the most common malignant tumors.Early diagnosis，chemotherapy，prognosis assessment and genetic diagnosis have a crucial impact on the treatment of lung cancer patients.Although there are a variety of imaging and laboratory indicators for preoperative early diagnosis of lung cancer，it is impossible to fully diagnose and accurately assess the prognosis.Circulating tumor cell technology，as a new type of "liquid biopsy" can timely diagnose early lung cancer，can evaluate the chemotherapy effect of lung cancer，and can also detect gene mutations.

References:

[1]BRAY F，FERLAY J，SOERJOMATARAM I，et al.Global cancer statistics 2018：GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries［J］.CA Cancer J Clin，2018，68：394-424.
[2]TORRE LA，BRAY F，SIEGEL RL，et al.Global cancer statistics，2012［J］.CA Cancer J Clin，2015，65：87-108.
[3]石远凯，孙燕，于金明，等.中国晚期原发性肺癌诊治专家共识.［J］.中国肺癌杂志，2016，19(1)：1-15. SHI YK，SUN Y，YU JM，et al.Consensus of experts on diagnosis and treatment of advanced primary lung cancer in China［J］.Chinese Journal of Lung Cancer，2016，19(1)：1-15.
[4]REBECCA LS，KIMBERLY DM，AHMEDIN J.Cancer statistics［J］.A Cancer Journal for Clinicians，2017，67(1)：7-30.
[5]ASHWORTH TR.A case of cancer in which cells similar to those in the tumors were seen in the blood after death［J］.Aust Med J，1869，14：146-149.
[6]SONG W，GOBE GC.Understanding molecular pathways and targets of brachyury in epithelial mesenchymal transition(EMT)in human cancers［J］.Curr Cancer Drug Targets，2016，16(7)：586-593.
[7]ALIX-PANABIRES C，MADER S，PANTEL K，et al.Epithelial-mesenchymal plasticity in circulating tumor cells［J］.Mol Med，2017，95：133-142.
[8]BARDELLI A，PANTEL K，LIQUID BIOPSIES.What we do not know(yet)［J］.Cancer Cell，2017，31，172-179.
[9]LI W，WANG H，ZHAO Z，et al.Emerging nanotechnologies forliquid biopsy：The detection of circulating tumor cells and extracellular vesicles［J］.Adv Mater Weinheim，2018，27：e1805344.
[10]SIRAVEGNA G，MARSONI S，SIENA S，et al.Integrating liquid biopsies into the management of cancer［J］.Nat Rev Clin Oncol，2017，14:531-548.
[11]SORBER L，ZWAENEPOEL K，DE WINNE K，et al.A Multicenter study to assess EGFR mutationalstatus in plasma：Focus on an optimized workflow for liquid biopsy in a clinical setting［J］.Cancers，2018，10(290)：2-14.
[12]ALIX-PANABIRES C，PANTEL K.Characterization of single circulating tumor cells［J］.FEBS Lett,2017,591(15)：2241-2250.
[13]HEYMANN D，TLLEZ-GABRIEL M.Circulating tumor cells：The importance of single cell analysis［J］.Adv Exp Med Biol，2018，1068：45-58.
[14]PALMIROTTA R，LOVERO D，SILVESTRIS E，et al.Next-generation sequencing(NGS) analysis on single circulating tumor cells(CTCs) with no need of whole-genome amplification(WGA)［J］.Cancer Genomics Proteomics，2017，14(3)：173-179.
[15]BROWN HK，TELLEZ-GABRIEL M，CARTRON PF，et al.Characterization of circulating tumor cells as a reflection of the tumor heterogeneity：Myth or reality［J］.Drug Discov Today，2019，24(3)：1-10.
[16]HOFMAN P.Liquid biopsy and therapeutic targets：Present and future issues in thoracic oncology［J］.Cancers，2017，9(154)：2-13.
[17]NTZIFA A，KROUPIS C，HALIASSOS A，et al.A pilot plasma-ctDNA ring trial for the CobasEGFR mutation test in clinical diagnostic laboratories［J］.Clin Chem Lab Med，2019，57(5)：1-5.
[18]ROLFO C，MACK PC，SCAGLIOTTI GV，et al.IASLC statement paper：Liquid biopsy for advanced non-small cell lung cancer(NSCLC)［J］.Thorac Oncol，2018，13(19):1248-1268.
[19]SACHER AG，ALDEN RS，OXNARD GR.Early intervention in lung cancers with rapid plasma genotyping for EGFR and KRAS mutations-reply［J］.JAMA Oncol，2016，2(18):1096-1097.
[20]CABANERO M，TSAO MS.Circulating tumour DNA in-mutant non-small-cell lung cancer［J］.Curr Oncol，2018，25(suppl 1)：38-44.
[21]KUANG Y，O'CONNELL A，SACHER AG,et al.Monitoring of response and resistance in plasma of EGFR-mutant lung cancer using droplet digital PCR［J］.Methods Mol Biol，2018，1768：193-207.
[22]SACHER AG，KOMATSUBARA KM，OXNARD GR.Application of plasma genotyping technologies in non-small cell lung cancer：A practical review［J］.J Thorac Oncol，2017，12(9)：1344-1356.
[23]SCHROCK AB，WELSH A，CHUNG JH，et al.Hybrid capture-based genomic profiling of circulating tumor DNA from patients with advanced non-small cell lung cancer［J］.J Thorac Oncol，2019，14(2)：1-10.
[24]DURNDEZ-SEZ E，AZKRATE A，MERI M，et al.New insights in non-small-cell lung cancer：Circulating tumor cells and cell-free DNA［J］.J Thorac Dis，2017，9(suppl 13)：1332-1345.
[25]WANG L，DUMENIL C，JULI C，et al.Molecular characterization of circulating tumor cells in lung cancer：Moving beyond enumeration［J］.Oncotarget，2017，8(65)：109818-109835.
[26]PANTEL K.Blood-based analysis of circulating cell-free dna and tumor cells for early cancer detection［J］.PLoS Med，2016，13(12)：e1002205.
[27]ROSSI G，MU Z，RADEMAKER AW，et al.Cell-free DNA and circulating tumor cells：Comprehensive liquid biopsy analysis in advanced breast cancer［J］.Clin Cancer Res，2018，24(3)：560-568.
[28]MORBELLI S，ALAMA A，FERRARAZZO G，et al.Circulating tumor DNA reflects tumor metabolism rather than tumor burden in chemotherapy-naive patients with advanced non-small cell lung cancer：F-FDG PET/CT study［J］.J Nucl Med，2017，58(11)：1764-1769.
[29]SUNDARESAN TK，SEQUIST LV，HEYMACH JV，et al.Detection of T790M，the acquired resistance egfr mutation，by tumor biopsy versus noninvasive blood-based analyses［J］.Clin Cancer Res，2016，22(5)：1103-1110.
[30]BOBEK V，GURLICH R，ELIASOVA P，et al.Circulating tumor cells in pancreatic cancer patients：Enrichment and cultivation［J］.World J Gastroenterol，2014，20(45)：17163-17170.
[31]LOW WS，WAN ABAS WA.Benchtop technologies for circulating tumor cells separation based on biophysical properties［J］.Biomed Res Int，2015，2015：1-22.
[32]DING Jing.Detection of circulation tumor cells by cellsearch sy-stem［J］.Medical Information，2013，26(4)：686.
[33]MARTA TELLEZ GABRIEL，LIDIA RODRIGUEZ CALLEJA.Circulating tumor cells：A review of non-EpCAM-based approaches for cell enrichment and isolation［J］.Clin Chem，2016，62(4)：571-581.
[34]PUNNOOSE EA，ATWAL S，LIU W，et al.Evaluation of circulating tumor cells and circulating tumor DNA in non-small cell lung cancer：Association with clinical endpoints in a phase II clinical trial of pertuzumab and erlotinib［J］.Clin Cancer Res，2012，18(8)：2391-2401.
[35]PANTEL K，DENE`VE E.Circulating epithelial cells in patients with benign colon diseases［J］.Clin Chem，2012，58(5)：936-940.
[36]MIKOLAJCZYK SD，MILLAR LS.Detection of EpCAM-negative and cytokeratin-negative circulating tumor cells in peripheral blood［J］.J Oncol，2011，2011：252361.
[37]FIORELLI A，ACCARDO M，CARELLI E，et al.Circulating tumor cells in diagnosing lung cancer：Clinical and morphologic analysis［J］.Ann Thorac Surg，2015，99(6)：1899-1905.
[38]ILIE M，HOFMAN V，LONG-MIRA E，et al."Sentinel" circulating tumor cells allow early diagnosis of lung cancer in patients with chronic obstructive pulmonary disease［J］.PLoS One，2014，9(10)：e111597.
[39]WANG L，WU C，QIAO L，et al.Clinical significance of folate receptor-positive circulating tumor cells detected by ligand-targeted polymerase chain reaction in lung cancer［J］.J Cancer,2017，8(1)：104-110.
[40]CHEN X，ZHOU F，LI X，et al.Folate receptor-positive circulating tumor cell detected by LT-PCR-based method as a diagnostic biomarker for non-small-cell lung cancer［J］.J Thorac Oncol，2015，10(8)：1163-1171.
[41]CHEN X，WANG X，HE H，et al.Combination of circulating tumor cells with serum carcinoembryonic antigen enhances clinical prediction of non-small cell lung cancer［J］.PLoS One，2015，10(5)：e126276.
[42]SONG IH，YEOM SW，HEO S，et al.Prognostic factors for post-recurrence survival in patients with completely resected stage Ⅰ non-small-cell lung cancer［J］.Eur J Cardiothorac Surg，2014，45(2)：262-267.
[43]MAESTRO LM，SASTRE J，RAFAEL SB，et al.Circulating tumor cells in solid tumor in metastatic and localized stages［J］.Anticancer Res，2009，29(11)：4839-4843.
[44]J MASSAGU,AC OBENAUF.Metastatic colonization by circulating tumour cells［J］.Nature，2016，529(7586)：298-306.
[45]JF DORSEY，GD KAO，KM MACARTHUR，et al.Tracking viable circulating tumor cells(CTCs) in the peripheral blood of non-small cell lung cancer(NSCLC) patients undergoing definitive radiation therapy：Pilot study results［J］.Cancer，2015，121(1)：139-149.
[46]KREBS MG，SLOANE R，PRIEST L，et al.Molecular characterization and prognostic significance of circulating tumor cells in patients with non-small cell lung cancer［J］.J Clin Oncol，2011，29(12)：1556-1563.
[47]BAYARRI-LARA C，ORTEGA FG，CUETO LADRN DE GUEVARA A，et al.Circulating tumor cells identify early recurrence in patients with non-small cell lung cancer undergoing radical resection［J］.PLoS One，2016，11(2)：e0148659.
[48]SZCZERBA BM，CASTRO-GINER F，VETTER M，et al.Neutrophils escort circulating tumour cells to enable cell cycle progression［J］.Nature，2019，566(7745)：553-557.
[49]YANAGITA M，REDIG AJ，PAWELETZ CP，et al.A Prospective evaluation of circulating tumor cells and cell-free DNA in EGFR-mutant non-small cell lung cancer patients treated with erlotinib on a phase II trial［J］.Clin Cancer Res，2016，22(24)：6010-6020.
[50]GAO W，HUANG T，YUAN H，et al.Highly sensitive detection and mutational analysis of lung cancer circulating tumor cells using integrated combined immunomagnetic beads with a droplet digital PCR chip［J］.Talanta，2018，185：229-236.
[51]HE J，TAN W，MA J，et al.Circulating tumor cells and DNA for real-time EGFR detection and monitoring of non-small-cell lung cancer［J］.Future Oncol，2017，13(9)：787-797.
[52]HOFMAN V，HEEKE S，MARQUETTE CH，et al.Circulating tumor cell detection in lung cancer：But to what end［J］.Cancers(Basel)，2019，11(2)：262-276.
[53]ZHANG Q，NONG J，WANG J，et al.Isolation of circulating tumor cells and detection of EGFR mutations in patients with non-small-cell lung cancer［J］.Oncol Lett，2019，17(4)：3799-3807.

Memo

Memo:
-
Last Update: 2021-01-02